Intercellular Crosstalk Between Cancer Cells and Cancer-associated Fibroblasts Via Exosomes in Gastrointestinal Tumors

Overview

Journal Front Oncol

Specialty Oncology

Date 2024 Mar 11

PMID 38463229

Authors

Longyang Cao

Hong Ouyang

Affiliations

Soon will be listed here.

Abstract

Gastrointestinal (GI) tumors are a significant global health threat, with high rates of morbidity and mortality. Exosomes contain various biologically active molecules like nucleic acids, proteins, and lipids and can serve as messengers for intercellular communication. They play critical roles in the exchange of information between tumor cells and the tumor microenvironment (TME). The TME consists of mesenchymal cells and components of the extracellular matrix (ECM), with fibroblasts being the most abundant cell type in the tumor mesenchyme. Cancer-associated fibroblasts (CAFs) are derived from normal fibroblasts and mesenchymal stem cells that are activated in the TME. CAFs can secrete exosomes to modulate cell proliferation, invasion, migration, drug resistance, and other biological processes in tumors. Additionally, tumor cells can manipulate the function and behavior of fibroblasts through direct cell-cell interactions. This review provides a summary of the intercellular crosstalk between GI tumor cells and CAFs through exosomes, along with potential underlying mechanisms.

Citing Articles

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E J Hematol Oncol. 2025; 18(1):6.

PMID: 39806516 PMC: 11733683. DOI: 10.1186/s13045-024-01634-6.

GPD1L may inhibit the development of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway: bioinformatics analysis and experimental exploration.

Gan L, Zhou L, Chu A, Sun C, Wang Y, Yang M Mol Biol Rep. 2024; 51(1):1149.

PMID: 39535578 DOI: 10.1007/s11033-024-10070-1.

PPIC-labeled CAFs: Key players in neoadjuvant chemotherapy resistance for gastric cancer.

Yin H, Sun L, Yuan Y, Zhu Y Transl Oncol. 2024; 48:102080.

PMID: 39116799 PMC: 11362775. DOI: 10.1016/j.tranon.2024.102080.

Decellularized tissues as platforms for digestive system cancer models.

Seifi Z, Khazaei M, Cheraghali D, Rezakhani L Heliyon. 2024; 10(11):e31589.

PMID: 38845895 PMC: 11153114. DOI: 10.1016/j.heliyon.2024.e31589.

Heterocellular Adhesion in Cancer Invasion and Metastasis: Interactions between Cancer Cells and Cancer-Associated Fibroblasts.

Yamaguchi H, Miyazaki M Cancers (Basel). 2024; 16(9).

PMID: 38730588 PMC: 11082996. DOI: 10.3390/cancers16091636.

References

Xu G, Zhang B, Ye J, Cao S, Shi J, Zhao Y . Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression. Int J Biol Sci. 2019; 15(11):2320-2329. PMC: 6775321. DOI: 10.7150/ijbs.33750. View

Xiang X, Niu Y, Wang Z, Ye L, Peng W, Zhou Q . Cancer-associated fibroblasts: Vital suppressors of the immune response in the tumor microenvironment. Cytokine Growth Factor Rev. 2022; 67:35-48. DOI: 10.1016/j.cytogfr.2022.07.006. View

Halbrook C, Lyssiotis C, Pasca di Magliano M, Maitra A . Pancreatic cancer: Advances and challenges. Cell. 2023; 186(8):1729-1754. PMC: 10182830. DOI: 10.1016/j.cell.2023.02.014. View

Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y . Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023; 22(1):55. PMC: 10024440. DOI: 10.1186/s12943-023-01759-1. View

Ansardamavandi A, Tafazzoli-Shadpour M . The functional cross talk between cancer cells and cancer associated fibroblasts from a cancer mechanics perspective. Biochim Biophys Acta Mol Cell Res. 2021; 1868(11):119103. DOI: 10.1016/j.bbamcr.2021.119103. View

Yang D, Liu J, Qian H, Zhuang Q . Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp Mol Med. 2023; 55(7):1322-1332. PMC: 10394065. DOI: 10.1038/s12276-023-01013-0. View

Zhou Y, Zhang X, Lu S, Zhang N, Zhang H, Zhang J . Human adipose-derived mesenchymal stem cells-derived exosomes encapsulated in pluronic F127 hydrogel promote wound healing and regeneration. Stem Cell Res Ther. 2022; 13(1):407. PMC: 9358082. DOI: 10.1186/s13287-022-02980-3. View

Wang Y, Li T, Yang L, Zhang X, Wang X, Su X . Cancer-associated fibroblast-released extracellular vesicles carrying miR-199a-5p induces the progression of gastric cancer through regulation of FKBP5-mediated AKT1/mTORC1 signaling pathway. Cell Cycle. 2022; 21(24):2590-2601. PMC: 9704384. DOI: 10.1080/15384101.2022.2105092. View

Guo S, Chen F, Li L, Dou S, Li Q, Huang Y . Intracellular Fusobacterium nucleatum infection increases METTL3-mediated m6A methylation to promote the metastasis of esophageal squamous cell carcinoma. J Adv Res. 2023; 61:165-178. PMC: 11258656. DOI: 10.1016/j.jare.2023.08.014. View

10.

Cai P, Zheng Y, Zhou Y, Wang W, Li M, Shi Y . Research progress on the role of exosomes in obstructive sleep apnea-hypopnea syndrome-related atherosclerosis. Sleep Med Rev. 2022; 66:101696. DOI: 10.1016/j.smrv.2022.101696. View

11.

Yang P, Zhang D, Wang T, Ji J, Jin C, Peng C . CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway. Cell Death Dis. 2022; 13(9):796. PMC: 9485119. DOI: 10.1038/s41419-022-05240-7. View

12.

Yang R, Wang D, Han S, Gu Y, Li Z, Deng L . MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs. Int J Biol Sci. 2022; 18(1):43-64. PMC: 8692143. DOI: 10.7150/ijbs.62602. View

13.

Bando H, Ohtsu A, Yoshino T . Therapeutic landscape and future direction of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 2023; 20(5):306-322. DOI: 10.1038/s41575-022-00736-1. View

14.

Tomlinson J, Valle J, Ilyas S . Immunobiology of cholangiocarcinoma. J Hepatol. 2023; 79(3):867-875. PMC: 10524996. DOI: 10.1016/j.jhep.2023.05.010. View

15.

Li Y, Wang C, Huang T, Yu X, Tian B . The role of cancer-associated fibroblasts in breast cancer metastasis. Front Oncol. 2023; 13:1194835. PMC: 10367093. DOI: 10.3389/fonc.2023.1194835. View

16.

Baile-Maxia S, Mangas-Sanjuan C, Ladabaum U, Hassan C, Rutter M, Bretthauer M . Risk Factors for Metachronous Colorectal Cancer or Advanced Adenomas After Endoscopic Resection of High-risk Adenomas. Clin Gastroenterol Hepatol. 2022; 21(3):630-643. DOI: 10.1016/j.cgh.2022.12.005. View

17.

Thrift A, Wenker T, El-Serag H . Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023; 20(5):338-349. DOI: 10.1038/s41571-023-00747-0. View

18.

Chen C, Yang C, Tian X, Liang Y, Wang S, Wang X . Downregulation of miR-100-5p in cancer-associated fibroblast-derived exosomes facilitates lymphangiogenesis in esophageal squamous cell carcinoma. Cancer Med. 2023; 12(13):14468-14483. PMC: 10358253. DOI: 10.1002/cam4.6078. View

19.

Lim M, Jantaree P, Naumann M . The conundrum of Helicobacter pylori-associated apoptosis in gastric cancer. Trends Cancer. 2023; 9(8):679-690. DOI: 10.1016/j.trecan.2023.04.012. View

20.

Dougherty M, Jobin C . Intestinal bacteria and colorectal cancer: etiology and treatment. Gut Microbes. 2023; 15(1):2185028. PMC: 10026918. DOI: 10.1080/19490976.2023.2185028. View